Ethics and Transparency
Partnership for Health System Sustainability and Resilience
The Partnership is a co-creation by LSE, the WEF and AstraZeneca to support the strengthening of the global public health ecosystem. The Partners are fully committed to complying with regulatory guidelines in the focus countries and to conducting project activities in an ethical, transparent and open manner, underpinned by principles of academic rigour and global good citizenship.
AstraZeneca is the sole funder of the Partnership but defers to the Steering Committee for all strategic decisions. AstraZeneca will have minority representation on the Steering Committee. The Partnership is entirely non-promotional and does not bear any relation to AstraZeneca products. Case studies written by external experts might highlight the importance of medicines, possibly in therapeutic areas where AstraZeneca is active, but will not be solely directed at AstraZeneca products. AstraZeneca recognizes that being part of the partnership may indirectly impact the business in positive ways.
Experts with substantial contributions to the project will be contracted and compensated through the LSE, in adherence with AstraZeneca principles such as market-specific Fair Market Value limits. No payments shall be made to people that are involved in decisions that directly affect AstraZeneca’s commercial performance, including but not limited to reimbursement of formulary listing decisions. AstraZeneca will disclose payments made as part of the partnership in accordance with its transparency policies.
GUIDING PRINCIPLES
- The Partnership will strive to obtain the right balance of rigour, detail and comprehensiveness with urgency in order to maximise its impact.
- The project methodology will be guided by principles of iteration, responsiveness, situational awareness and continued refinement based on evaluations throughout the project.
- The success of the Partnership will ultimately be measured by the nature, extent and distribution of its impacts in improving the resilience and sustainability of health systems worldwide.
- The Partnership’s success will be underpinned by the validity, legitimacy and acceptance of its methodology by stakeholders in global health and international health systems.
- The Partnership will take a critical and progressive stance with regards to the development of the framework, policy recommendations, practical solutions, ‘spin-off’ projects and partnerships to promote change, but will not be dismissive of existing and established approaches.
- The Partnership will not recommend a one-fits-all approach. All project outputs will aim to take account of the differences in circumstances faced by health systems around the world.
